A recent analysis of the molecular profiles of patients with HCC (n = 520) from two independent cohorts, confirmed the aberrant tumor overexpression of AFP in patients with serum concentrations >400 ng/mL (AFP-high tumors) [98]. This evidence concerns the gene AFP and hepatocellular carcinoma.